SMYD3:在分化的早期阶段,脂肪细胞前体增殖的新调节者
Tatjana Sajic1,2, Chayenne Karine Ferreira Gomes2, Marie Gasser1,2
1Unit of Forensic Toxicology and Chemistry, CURML, Lausanne and Geneva University Hospitals, Lausanne, Geneva, Switzerland.
International journal of obesity (2005)
|December 26, 2023
概括
研究人员确定SMYD3是健康脂肪细胞扩张的关键调节者. 降低SMYD3限制新的脂肪细胞生长,突出其在脂肪生成中的作用和预防与肥胖相关的炎症.
科学领域:
- 分子生物学分子生物学
- 代谢研究的研究.
- 细胞生物学 细胞生物学
背景情况:
- 肥胖症涉及脂肪组织的重塑,高成形 (新的脂肪细胞) 比高 (扩大的脂肪细胞) 更健康.
- 过度缩扩张与炎症和代谢功能障碍有关.
- 调节脂肪组织扩张的机制尚未完全理解.
研究的目的:
- 确定区分健康 (低炎症) 和不健康 (高炎症) 脂肪组织扩张的分子机制.
- 为了研究已识别的蛋白质在脂肪生成中的功能.
主要方法:
- 来自高脂肪饮食 (HFD) 的小鼠内脏白脂肪组织 (vWAT) 的蛋白质组分析.
- 从低炎症 (Low-INFL) 和高炎症 (Hi-INFL) 组进行vWAT的比较.
- 使用分化为脂肪细胞的脂肪酶衍生人间甲基细胞干细胞 (AD-hMSCs) 进行的功能研究.
主要成果:
- 蛋白质组学确定了6051种蛋白质,其中SMYD3 (含有SET和MYND域3) 是一个关键的差异化因素.
- 在低INFL的vWAT中,SMYD3的表达更高.
- 在AD-hMSC中,SMYD3的淘汰减少了增殖和脂肪生成,影响了H3K4me3水平.
结论:
- SMYD3 作为脂肪细胞前体增殖的新型调节剂.
- 在脂肪生成的早期阶段,SMYD3起着至关重要的作用.
- 了解SMYD3的功能可以为管理脂肪组织扩张提供新的策略.
更多相关视频
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
1.4K
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
3.6K
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
